ARWR News
Arrowhead Pharmaceuticals, Inc.
$58.37
+$0.24(+0.41%)
33
Overall
40
Value
18
Tech
42
Quality
Market Cap
$8.25B
Volume
4.16M
52W Range
$34.61 - $95.49
Target Price
$107.23
ARWR news: the latest Arrowhead Pharmaceuticals, Inc. headlines, press releases and market updates, newest first.
Latest ARWR News
- Arrowhead Pharmaceuticals (ARWR) Receives a New Rating from UBSTipRanks Auto-Generated Intelligence Newsdesk · Oct 14, 2026
- Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF), Humana (HUM) and Arrowhead Pharmaceuticals (ARWR)TipRanks Newsroom · Oct 12, 2026
- Arrowhead’s Plozasiran Trial Completion Signals a Pivotal Moment for ARWR InvestorsTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 9, 2026
- Arrowhead’s Plozasiran Hits Phase 3 Completion: What Investors Should Watch NextTipRanks Clinical-Trials-Auto-Generated Newsdesk · Oct 8, 2026
- Arrowhead’s Plozasiran Trial Completion Marks a Key Catalyst in the Triglyceride MarketTipRanks Clinical-Trials-Auto-Generated Newsdesk · Sep 25, 2026
- Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST) and Arrowhead Pharmaceuticals (ARWR)TipRanks Newsroom · Sep 24, 2026
- Arrowhead Pharmaceuticals (ARWR) Receives a Rating Update from a Top AnalystTipRanks Auto-Generated Intelligence Newsdesk · Sep 21, 2026
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ARWR | $58.37 | +0.4% | 4.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Arrowhead Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW